The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drugs for Traveler's Diarrhea-Global Market Insights and Sales Trends 2025
Synopsis
The global Drugs for Traveler's Diarrhea market size is expected to reach US$ 1159.1 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Drugs for Traveler's Diarrhea in various end use industries. The expanding demands from the Adult and Children, are propelling Drugs for Traveler's Diarrhea market. Anti-motility agents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bismuth Subsalicylate (Pepto-Bismol) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drugs for Traveler's Diarrhea market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drugs for Traveler's Diarrhea market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drugs for Traveler's Diarrhea sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drugs for Traveler's Diarrhea covered in this report include GSK, Salix Pharmaceuticals, Chiesi Farmaceutici, Cosmo Pharmaceuticals, Nippon Shinyaku, Prokarium Limited, Scandinavian Biopharma and Sigmoid Pharma, etc.
The global Drugs for Traveler's Diarrhea market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Salix Pharmaceuticals
Chiesi Farmaceutici
Cosmo Pharmaceuticals
Nippon Shinyaku
Prokarium Limited
Scandinavian Biopharma
Sigmoid Pharma
Global Drugs for Traveler's Diarrhea market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drugs for Traveler's Diarrhea market, Segment by Type:
Anti-motility agents
Bismuth Subsalicylate (Pepto-Bismol)
Antibiotics
Global Drugs for Traveler's Diarrhea market, by Application
Adult
Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drugs for Traveler's Diarrhea manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drugs for Traveler's Diarrhea in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Drugs for Traveler's Diarrhea market size is expected to reach US$ 1159.1 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Drugs for Traveler's Diarrhea in various end use industries. The expanding demands from the Adult and Children, are propelling Drugs for Traveler's Diarrhea market. Anti-motility agents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bismuth Subsalicylate (Pepto-Bismol) segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drugs for Traveler's Diarrhea, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drugs for Traveler's Diarrhea market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drugs for Traveler's Diarrhea market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drugs for Traveler's Diarrhea sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drugs for Traveler's Diarrhea covered in this report include GSK, Salix Pharmaceuticals, Chiesi Farmaceutici, Cosmo Pharmaceuticals, Nippon Shinyaku, Prokarium Limited, Scandinavian Biopharma and Sigmoid Pharma, etc.
The global Drugs for Traveler's Diarrhea market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Salix Pharmaceuticals
Chiesi Farmaceutici
Cosmo Pharmaceuticals
Nippon Shinyaku
Prokarium Limited
Scandinavian Biopharma
Sigmoid Pharma
Global Drugs for Traveler's Diarrhea market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drugs for Traveler's Diarrhea market, Segment by Type:
Anti-motility agents
Bismuth Subsalicylate (Pepto-Bismol)
Antibiotics
Global Drugs for Traveler's Diarrhea market, by Application
Adult
Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Drugs for Traveler's Diarrhea manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Drugs for Traveler's Diarrhea in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Drugs for Traveler's Diarrhea Market Overview
1.1 Drugs for Traveler's Diarrhea Product Overview
1.2 Drugs for Traveler's Diarrhea Market Segment by Type
1.2.1 Anti-motility agents
1.2.2 Bismuth Subsalicylate (Pepto-Bismol)
1.2.3 Antibiotics
1.3 Global Drugs for Traveler's Diarrhea Market Size by Type
1.3.1 Global Drugs for Traveler's Diarrhea Market Size Overview by Type (2018-2029)
1.3.2 Global Drugs for Traveler's Diarrhea Historic Market Size Review by Type (2018-2023)
1.3.3 Global Drugs for Traveler's Diarrhea Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Drugs for Traveler's Diarrhea Sales Breakdown by Type (2018-2023)
1.4.2 Europe Drugs for Traveler's Diarrhea Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Drugs for Traveler's Diarrhea Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Drugs for Traveler's Diarrhea Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Drugs for Traveler's Diarrhea Sales Breakdown by Type (2018-2023)
2 Global Drugs for Traveler's Diarrhea Market Competition by Company
2.1 Global Top Players by Drugs for Traveler's Diarrhea Sales (2018-2023)
2.2 Global Top Players by Drugs for Traveler's Diarrhea Revenue (2018-2023)
2.3 Global Top Players by Drugs for Traveler's Diarrhea Price (2018-2023)
2.4 Global Top Manufacturers Drugs for Traveler's Diarrhea Manufacturing Base Distribution, Sales Area, Product Type
2.5 Drugs for Traveler's Diarrhea Market Competitive Situation and Trends
2.5.1 Drugs for Traveler's Diarrhea Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Drugs for Traveler's Diarrhea Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drugs for Traveler's Diarrhea as of 2022)
2.7 Date of Key Manufacturers Enter into Drugs for Traveler's Diarrhea Market
2.8 Key Manufacturers Drugs for Traveler's Diarrhea Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Drugs for Traveler's Diarrhea Status and Outlook by Region
3.1 Global Drugs for Traveler's Diarrhea Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Drugs for Traveler's Diarrhea Historic Market Size by Region
3.2.1 Global Drugs for Traveler's Diarrhea Sales in Volume by Region (2018-2023)
3.2.2 Global Drugs for Traveler's Diarrhea Sales in Value by Region (2018-2023)
3.2.3 Global Drugs for Traveler's Diarrhea Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Drugs for Traveler's Diarrhea Forecasted Market Size by Region
3.3.1 Global Drugs for Traveler's Diarrhea Sales in Volume by Region (2024-2029)
3.3.2 Global Drugs for Traveler's Diarrhea Sales in Value by Region (2024-2029)
3.3.3 Global Drugs for Traveler's Diarrhea Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Drugs for Traveler's Diarrhea by Application
4.1 Drugs for Traveler's Diarrhea Market Segment by Application
4.1.1 Adult
4.1.2 Children
4.2 Global Drugs for Traveler's Diarrhea Market Size by Application
4.2.1 Global Drugs for Traveler's Diarrhea Market Size Overview by Application (2018-2029)
4.2.2 Global Drugs for Traveler's Diarrhea Historic Market Size Review by Application (2018-2023)
4.2.3 Global Drugs for Traveler's Diarrhea Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Drugs for Traveler's Diarrhea Sales Breakdown by Application (2018-2023)
4.3.2 Europe Drugs for Traveler's Diarrhea Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Drugs for Traveler's Diarrhea Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Drugs for Traveler's Diarrhea Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Drugs for Traveler's Diarrhea Sales Breakdown by Application (2018-2023)
5 North America Drugs for Traveler's Diarrhea by Country
5.1 North America Drugs for Traveler's Diarrhea Historic Market Size by Country
5.1.1 North America Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Drugs for Traveler's Diarrhea Sales in Volume by Country (2018-2023)
5.1.3 North America Drugs for Traveler's Diarrhea Sales in Value by Country (2018-2023)
5.2 North America Drugs for Traveler's Diarrhea Forecasted Market Size by Country
5.2.1 North America Drugs for Traveler's Diarrhea Sales in Volume by Country (2024-2029)
5.2.2 North America Drugs for Traveler's Diarrhea Sales in Value by Country (2024-2029)
6 Europe Drugs for Traveler's Diarrhea by Country
6.1 Europe Drugs for Traveler's Diarrhea Historic Market Size by Country
6.1.1 Europe Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Drugs for Traveler's Diarrhea Sales in Volume by Country (2018-2023)
6.1.3 Europe Drugs for Traveler's Diarrhea Sales in Value by Country (2018-2023)
6.2 Europe Drugs for Traveler's Diarrhea Forecasted Market Size by Country
6.2.1 Europe Drugs for Traveler's Diarrhea Sales in Volume by Country (2024-2029)
6.2.2 Europe Drugs for Traveler's Diarrhea Sales in Value by Country (2024-2029)
7 Asia-Pacific Drugs for Traveler's Diarrhea by Region
7.1 Asia-Pacific Drugs for Traveler's Diarrhea Historic Market Size by Region
7.1.1 Asia-Pacific Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Drugs for Traveler's Diarrhea Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Drugs for Traveler's Diarrhea Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Drugs for Traveler's Diarrhea Forecasted Market Size by Region
7.2.1 Asia-Pacific Drugs for Traveler's Diarrhea Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Drugs for Traveler's Diarrhea Sales in Value by Region (2024-2029)
8 Latin America Drugs for Traveler's Diarrhea by Country
8.1 Latin America Drugs for Traveler's Diarrhea Historic Market Size by Country
8.1.1 Latin America Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Drugs for Traveler's Diarrhea Sales in Volume by Country (2018-2023)
8.1.3 Latin America Drugs for Traveler's Diarrhea Sales in Value by Country (2018-2023)
8.2 Latin America Drugs for Traveler's Diarrhea Forecasted Market Size by Country
8.2.1 Latin America Drugs for Traveler's Diarrhea Sales in Volume by Country (2024-2029)
8.2.2 Latin America Drugs for Traveler's Diarrhea Sales in Value by Country (2024-2029)
9 Middle East and Africa Drugs for Traveler's Diarrhea by Country
9.1 Middle East and Africa Drugs for Traveler's Diarrhea Historic Market Size by Country
9.1.1 Middle East and Africa Drugs for Traveler's Diarrhea Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Drugs for Traveler's Diarrhea Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Drugs for Traveler's Diarrhea Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Drugs for Traveler's Diarrhea Forecasted Market Size by Country
9.2.1 Middle East and Africa Drugs for Traveler's Diarrhea Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Drugs for Traveler's Diarrhea Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Drugs for Traveler's Diarrhea Products Offered
10.1.5 GSK Recent Development
10.2 Salix Pharmaceuticals
10.2.1 Salix Pharmaceuticals Company Information
10.2.2 Salix Pharmaceuticals Introduction and Business Overview
10.2.3 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Salix Pharmaceuticals Drugs for Traveler's Diarrhea Products Offered
10.2.5 Salix Pharmaceuticals Recent Development
10.3 Chiesi Farmaceutici
10.3.1 Chiesi Farmaceutici Company Information
10.3.2 Chiesi Farmaceutici Introduction and Business Overview
10.3.3 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Chiesi Farmaceutici Drugs for Traveler's Diarrhea Products Offered
10.3.5 Chiesi Farmaceutici Recent Development
10.4 Cosmo Pharmaceuticals
10.4.1 Cosmo Pharmaceuticals Company Information
10.4.2 Cosmo Pharmaceuticals Introduction and Business Overview
10.4.3 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Cosmo Pharmaceuticals Drugs for Traveler's Diarrhea Products Offered
10.4.5 Cosmo Pharmaceuticals Recent Development
10.5 Nippon Shinyaku
10.5.1 Nippon Shinyaku Company Information
10.5.2 Nippon Shinyaku Introduction and Business Overview
10.5.3 Nippon Shinyaku Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Nippon Shinyaku Drugs for Traveler's Diarrhea Products Offered
10.5.5 Nippon Shinyaku Recent Development
10.6 Prokarium Limited
10.6.1 Prokarium Limited Company Information
10.6.2 Prokarium Limited Introduction and Business Overview
10.6.3 Prokarium Limited Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Prokarium Limited Drugs for Traveler's Diarrhea Products Offered
10.6.5 Prokarium Limited Recent Development
10.7 Scandinavian Biopharma
10.7.1 Scandinavian Biopharma Company Information
10.7.2 Scandinavian Biopharma Introduction and Business Overview
10.7.3 Scandinavian Biopharma Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Scandinavian Biopharma Drugs for Traveler's Diarrhea Products Offered
10.7.5 Scandinavian Biopharma Recent Development
10.8 Sigmoid Pharma
10.8.1 Sigmoid Pharma Company Information
10.8.2 Sigmoid Pharma Introduction and Business Overview
10.8.3 Sigmoid Pharma Drugs for Traveler's Diarrhea Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Sigmoid Pharma Drugs for Traveler's Diarrhea Products Offered
10.8.5 Sigmoid Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Drugs for Traveler's Diarrhea Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Drugs for Traveler's Diarrhea Industrial Chain Analysis
11.4 Drugs for Traveler's Diarrhea Market Dynamics
11.4.1 Drugs for Traveler's Diarrhea Industry Trends
11.4.2 Drugs for Traveler's Diarrhea Market Drivers
11.4.3 Drugs for Traveler's Diarrhea Market Challenges
11.4.4 Drugs for Traveler's Diarrhea Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Drugs for Traveler's Diarrhea Distributors
12.3 Drugs for Traveler's Diarrhea Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
